Hepatitis Treatments

Find Hepatitis Treatments

Generic Name

Lamivudine

Brand Names

Abacavir, Efavirenz, Cimduo, Epivir, Delstrigo, SYMFI, Combivir, Triumeq, Dovato

FDA approval date: October 04, 2010

Classification: Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Form: Tablet, Kit, Solution

What is Abacavir (Lamivudine)?

Efavirenz, lamivudine and tenofovir disoproxil fumarate tablets are indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 infection in adult and pediatric patients weighing at least 35 kg. Efavirenz, lamivudine and tenofovir disoproxil fumarate tablets are three-drug combination of efavirenz , a non-nucleoside reverse transcriptase inhibitor, and lamivudine and tenofovir disoproxil fumarate , both nucleoside reverse transcriptase inhibitors and are indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 infection in adult and pediatric patients weighing at least 35 kg.

Approved To Treat

Top Global Experts

View All

Save this treatment for later

Not sure about your diagnosis?

Check Your Symptoms

Tired of the same old research?

Check Latest Advances

Related Clinical Trials

Co-benefits of Co-delivery of Long-acting Antiretrovirals and Contraceptives

Enrollment Status: Recruiting

Publish Date: April 13, 2026

Intervention Type: Drug

Study Phase: Not Applicable

Summary: The study investigators are conducting foundational pharmacokinetic (PK) and qualitative studies, among 15-24 years old (inclusive) adolescent girls and young women living with HIV (AGYWLHIV) already on oral antiretroviral therapy (ART) and virally suppressed, leading up to a hybrid type I effectiveness-implementation trial randomizing individual AGYWLHIV to receive long-acting (LA) injectable cab...

Phase II Trial of Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

Who is this study for: Patients with peripheral T cell lymphoma

Enrollment Status: Recruiting

Publish Date: March 30, 2026

Intervention Type: Drug, Procedure

Study Drugs: IOC, GVHD prophylaxis, RIC, mRIC, ATL-RIC

Study Phase: Phase 2

Background: Lymphoma is a type of blood cancer. Blood cell transplant can cure some people with lymphoma. Researchers want to see if they can limit the complications transplant can cause.

Exploration of Intra-individual Variability of Exposure to Emtricitabine and Lamivudine in Hair With a View to Validating the Value of This Matrix as a Diagnostic Tool for Partial and/or Total Non-compliance With Antiretroviral Treatment

Enrollment Status: Recruiting

Publish Date: March 23, 2026

Intervention Type: Other

Summary: Treatment adherence is defined by compliance with the dosage schedule (i.e., dose per dose and number of doses per day), as well as the duration of administration (i.e., number of days during which the dosage schedule must be followed). Treatment adherence determines the therapeutic efficacy and the absence of toxicity of the prescribed medication. However, this adherence is far from being respect...

View All Clinical Trials